The document discusses designer babies, defined as genetically modified infants with selected traits achieved through genetic engineering methods like pre-implantation genetic diagnosis and CRISPR technology. It outlines the potential benefits, such as reducing genetic disorders and allowing for gender selection, alongside significant ethical concerns, risks, and social implications including inequality and discrimination. The case of gene-edited babies in China emphasizes the urgent need for improved ethical governance in genetic engineering practices.